前收市價 | 105.03 |
開市 | 105.66 |
買盤 | 97.16 x 900 |
賣出價 | 110.00 x 900 |
今日波幅 | 101.57 - 107.25 |
52 週波幅 | 54.38 - 108.22 |
成交量 | |
平均成交量 | 518,401 |
市值 | 5.365B |
Beta 值 (5 年,每月) | 1.10 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.88 |
業績公佈日 | 2024年7月31日 - 2024年8月05日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 109.00 |
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.
Glaukos (GKOS) delivered earnings and revenue surprises of -20.69% and 8.83%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, GKOS, SRDX and ARAY are placed ahead of their earnings releases.